TG Therapeutics Inc (TGTX)

[stockguard]

Another thing the market is discounting:

TG Therapeutics, Inc. Recaps Clinical Data Presentations At The Upcoming 7th Joint ECTRIMS - ACTRIMS Meeting Oct 16, 2017 7:30 AM EDT

B-cell depletion data and MRI data at 24 weeks (6 months) to be presented

Abstract data shows complete (100%) elimination of T1 Gd-enhancing lesions at week 24



Michael S. Weiss, the Company's Executive Chairman and Chief Executive Officer stated, "We are excited to release the first clinical MRI data of TG-1101 in patients with RMS as we believe the abstract data presents an extremely compelling case for the use of TG-1101 in the treatment of patients with MS. While still early, the data thus far is setting the stage for a best-in-class profile for TG-1101 in treating MS. We are looking forward to presenting the full data on the first three cohorts (n=24) through 24 weeks (6 months) of treatment at the ECTRIMS-ACTRIMS meeting next week." Mr. Weiss continued, "We will continue to update these data at multiple conferences over the next year as we treat and follow the full 48 patients (from the 6 cohorts) for up to 1 year. With our Phase 3 program now underway pursuant to a Special Protocol Assessment (SPA), we believe MS represents the next level of growth for the Company."